Drugs & TargetsFree FDA approves chemoimmunotherapy regimen in diffuse large B-cell lymphoma June 14, 2019Vol.45 No.24
Drugs & Targets FDA grants Priority Review for daratumumab combination in multiple myeloma June 07, 2019Vol.45 No.23
Drugs & Targets Caris Life Sciences partners with Debiopharm International SA June 07, 2019Vol.45 No.23
Drugs & TargetsFree FDA approves lenalidomide for follicular and marginal zone lymphoma May 31, 2019Vol.45 No.22
